Tm Bioscience Corporation Signs Distribution Agreement With SanBio, Inc. To Commercialize The ID-Tag(TM) Respiratory Viral Panel In The Netherlands

TORONTO, June 16 /CNW/ - Tm Bioscience Corporation (Toronto, Ontario; TSX: TMC), a leader in the commercial genetic testing market, today announced it has signed a distribution agreement with Sanbio b.v. to commercialize the ID-Tag(TM) Respiratory Viral Panel (RVP) from Tm in the Netherlands. The ID-Tag(TM) RVP detects and discriminates between 20 respiratory viruses including Avian Flu and SARS.
MORE ON THIS TOPIC